MLA News Selected Articles

October 1999

MLA 2000/2001 Election Slate Announced

Submitted by Rachael K. Anderson, AHIP,
Chair, Nominating Committee

The 1999/2000 Nominating Committee is pleased to announce the following slate of candidates for the 2000 election.

President-Elect
(one to be elected)
Carol G. Jenkins, AHIP, Chapel Hill, NC
Linda A. Watson, AHIP, Charlottesville, VA

Board of Directors
(two to be elected)
Tom Flemming, AHIP, Hamilton, ON, Canada
Martha (Marty) Adamson, AHIP, Dallas, TX
Mark Funk, AHIP, New York
Lynn Fortney, Birmingham, AL

Nominating Committee
(nine to be elected)
Nancy W. Clemmons, AHIP, Birmingham, AL
Elaine Russo Martin, AHIP, Worcester, MA
Alexandra Dimitroff, Ph.D., AHIP, Milwaukee, WI
Janis F. Brown, AHIP, Los Angeles
Mary J. Jarvis, AHIP, Pampa, TX
James Shedlock, AHIP, Chicago
Margaret Bandy, AHIP, Denver, CO
Marlene Saul Englander, AHIP, Cleveland, OH
Elizabeth R. Warner, AHIP, Philadelphia
Amy Gische Lyons, Buffalo, NY
Audrey Powderly Newcomer, AHIP, St. Louis, MO
Lynn Siemers, Washington, DC
Donna B. Flake, AHIP, Wilmington, NC
Nancy Bush Fazzone, AHIP, Salem, MA
Heidi Heilemann, AHIP, Stanford, CA
Jett McCann, AHIP, Birmingham, AL
Jo Anne Boorkman, AHIP, Davis, CA
Margaret (Peg) Allen, AHIP, Stratford, WI

All voting members of MLA will receive ballots in the mail in November and will have until Friday, December 17, 1999, to postmark return ballots. Candidate background information will be published in the November/December MLA News and will be available on MLANET. The Nominating Committee encourages members to vote in this election.

Finding Newly Approved Drug Information

Edited by Melissa L. Just

Submitted by Robert H. Schrimsher, Ed.D., Drug Information Center; and Stephanie Gooch Wright, Pharm.D., McWhorter School of Pharmacy, Samford University, Birmingham, AL

Finding information on drugs that have been recently approved (know as newly approved drugs) by the U.S. Food and Drug Administration (FDA) can be an exasperating experience. For the purposes of this article, "newly approved" is defined as drugs approved within the last few months or even days. Some useful and timely print and electronic resources are available to track newly approved drugs and other items of interest. Monthly or weekly updates are a prerequisite for resources to be included in this article. Listed with pricing information and a brief annotation are some primary print and electronic sources that provide timely information concerning newly approved drugs.

Print Resources

Internet Resources for New Drug Approvals

Other Electronic Sources

Hepatitis C Websites

Edited by Melissa L. Just

Submitted by Candice Benjes, Norris Medical Library, University of Southern California–Los Angeles

Although the incidence of hepatitis C virus (HCV) has declined in the past decade, the death toll is increasing. The Centers for Disease Control (CDC) estimates 36,000–242,000 people are infected each year in the United States; of these, less than 30% have symptoms. Millions who were infected years earlier are just now feeling the effects of the virus. The FDA’s recent approval of a home test for hepatitis C and criticism regarding the government’s slow notification of infection program has raised the profile of this disease.

Internet Resources